Lawrence Mwananyanda, MD
Adjunct Research Assistant Professor
Boston University School of Public Health
Dept of Global Health

MD, Jagiellonian University
MPH, University of Alabama at Birmingham

Dr.Lawrence Mwananyanda is a clinician/scientist with a wealth of experience in conducting medical and public health research. He has been Principal Investigator or Co-PI on multiple research project. His portfolio includes being the Director of the HIV Vaccines Trials Unit at the Botswana Harvard Partnership where he and colleagues worked on the first Phase 1 HIV vaccine trials to be conducted in Africa. His interest with HIV vaccines research continued with his stint at the Emory University under the Zambia HIV Research Project where they studied conformational changes of the HIV at infection in a cohort of discordant couples to aid in design of next generation HIV trial vaccines.
With colleagues at Boston University, Dr.Mwananyanda’s focus has been research on child survival. Ongoing research include the Zambia Pertussis RSV Infant Mortality Estimation Study (ZPRIME) Southern Africa Mother Infant Pertussis Study – Nasopharyngeal Carriage (SAMIPS-NPC), Zambia Infant Cohort Study (ZICS) whose overall goal is to determine if HIV-exposed but uninfected infants (HEU) infants born to HIV-infected mothers on antiretroviral therapy have increased morbidity and mortality, and to correlate maternal Immune Activation ( with infant clinical outcome, and immune dysregulation as a potential mechanism for the poor HEU outcome. All these studies are based in Lusaka, Zambia. Dr. Mwananyanda is also the Zambia Site Director for the Harvard-Boston University-Northwestern University-New Mexico Fogarty Global Health program.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Gunning CE, Mwananyanda L, MacLeod WB, Mwale M, Thea DM, Pieciak RC, Rohani P, Gill CJ. Implementation and adherence of routine pertussis vaccination (DTP) in a low-resource urban birth cohort. BMJ Open. 2020 Dec 31; 10(12):e041198.View Related Profiles. PMID: 33384391
  2. Gill CJ, Gunning CE, MacLeod W, Mwananyanda L, Thea D, Pieciak R, Kwenda G, Mupila Z, Rohani P. Asymptomatic Bordetella pertussis infections in young African infants and their mothers identified within a longitudinal cohort. medRxiv. 2020 Nov 19.View Related Profiles. PMID: 33236026
  3. Cowden C, Mwananyanda L, Hamer DH, Coffin SE, Kapasa ML, Machona S, Szymczak JE. Healthcare worker perceptions of the implementation context surrounding an infection prevention intervention in a Zambian neonatal intensive care unit. BMC Pediatr. 2020 09 10; 20(1):432.View Related Profiles. PMID: 32912138
  4. Westling T, Cowden C, Mwananyanda L, Kapasa ML, Machona S, Pierre C, Mitra N, Hamer DH, Coffin SE. Impact of chlorhexidine baths on suspected sepsis and bloodstream infections in hospitalized neonates in Zambia. Int J Infect Dis. 2020 Jul; 96:54-60.View Related Profiles. PMID: 32304821
  5. Gallagher KE, Knoll MD, Prosperi C, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SRC, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, O'Brien KL, Thea DM, Awori JO, Baillie VL, Ebruke BE, Goswami D, Kamau A, Maloney SA, Moore DP, Mwananyanda L, Olutunde EO, Seidenberg P, Sissoko S, Sylla M, Thamthitiwat S, Zaman K, Scott JAG. The Predictive Performance of a Pneumonia Severity Score in Human Immunodeficiency Virus-negative Children Presenting to Hospital in 7 Low- and Middle-income Countries. Clin Infect Dis. 2020 03 03; 70(6):1050-1057.View Related Profiles. PMID: 31111870
  6. Nichols BE, Girdwood SJ, Shibemba A, Sikota S, Gill CJ, Mwananyanda L, Noble L, Stewart-Isherwood L, Scott L, Carmona S, Rosen S, Stevens W. Cost and Impact of Dried Blood Spot Versus Plasma Separation Card for Scale-up of Viral Load Testing in Resource-limited Settings. Clin Infect Dis. 2020 03 03; 70(6):1014-1020.View Related Profiles. PMID: 31321438
  7. Camelo IY, Mwananyanda LM, Thea DM, Seidenberg P, Gill CJ, Weinstein JR. A Tale of 2 Pneumos: The Impact of Human Immunodeficiency Virus Exposure or Infection Status on Pediatric Nasopharyngeal Carriage of Streptococcus pneumoniae and Pneumocystis jiroveci: A Nested Case Control Analysis From the Pneumonia Etiology Research In Child Health Study. Clin Infect Dis. 2020 Feb 15.View Related Profiles. PMID: 32342105
  8. Mwananyanda L, Pierre C, Mwansa J, Cowden C, Localio AR, Kapasa ML, Machona S, Musyani CL, Chilufya MM, Munanjala G, Lyondo A, Bates MA, Coffin SE, Hamer DH. Preventing Bloodstream Infections and Death in Zambian Neonates: Impact of a Low-cost Infection Control Bundle. Clin Infect Dis. 2019 09 27; 69(8):1360-1367.View Related Profiles. PMID: 30596901
  9. Hamer DH, Hansoti B, Prabhakaran D, Huffman MD, Nxumalo N, Fox MP, Gopal S, Oberhelman R, Mwananyanda L, Vwalika B, Rispel LC. Global Health Research Mentoring Competencies for Individuals and Institutions in Low- and Middle-Income Countries. Am J Trop Med Hyg. 2019 01; 100(1_Suppl):15-19.View Related Profiles. PMID: 30430976
  10. Larson Williams A, Mitrovich R, Mwananyanda L, Gill C. Maternal vaccine knowledge in low- and middle-income countries-and why it matters. Hum Vaccin Immunother. 2019; 15(2):283-286.View Related Profiles. PMID: 30252609
Showing 10 of 58 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 58 publications over 17 distinct years, with a maximum of 7 publications in 2020


Recent (within 3 months)

No, COVID-19 hasn’t ‘skipped’ Africa

Futurity 1/6/2021
Contact for Mentoring:

Lusaka, Zambia
Lusaka 09 10101
Google Map

Mwananyanda's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department